General Partner at Zentynel Frontier Investments - Santiago, Santiago Metropolitan Region, Chile
Venture Capital as an asset class offers attractive returns and Biotechnology offers the strongest and most consistent returns. VC has shown inverse correlation against public markets and biotech startups serve a Global Market with local costs. Zentynel offers investors privileged exposureand access to advanced knowledge in biotech in human health, animal health, agroindustry, food, energy, industrial procesess and VC in Latin America.Significant social impact by induction of private capital in R&D that can SOLVE PRESSING GLOBAL CHALLENGES.